Gilead Sciences Inc (GILD) — Analysis Summary
Gilead Sciences Inc (GILD) has a market cap of $166.82B with year-over-year revenue growth of +2.4%. Net margin stands at 28.9%. The stock trades at a P/E ratio of 18.1.
Key Takeaways
- Revenue changed +2.4% year-over-year
- Net margin of 28.9%
- P/E ratio of 18.1
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, GILD posted revenue growth of +2.4% and trades at a P/E of 18.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.